US Pharma MarketingLive at 12 p.m. today: Are the China hawks winning?
Post-Hoc Live debates who Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation power FDA policy and drug…
I don't know who will win the debate on China biotech in Washington, but I do know which voices are the loudest.
Over the past few months, China hawks — those who want to put up ...
Source: Endpoints News